hotspot -WSS

hotspot

author：Wikipedia 2025-10-02 04:13:19 - browse：383

Element Biosciences exterior -- biotech coverage from STAT — Element Biosciences exterior Element Biosciences

SAN DIEGO — Companies racing to read the genome accurately, quickly, and affordably have hit a snag recently, with several firms reporting that their growth has slowed, stalled, or reversed. Upstart Element Biosciences is hoping it can succeed despite the challenging market conditions.

The San Diego firm launched a $290,000 sequencer, dubbed Aviti, in March 2022 and now has 150 instruments installed in more than 25 countries, according to a sales update Element shared with STAT. The modest growth comes at a time when some other players are struggling. Singular Genomics announced layoffs of 20% of its workforce earlier this year after the lackluster launch of its own sequencer. And Pacific Biosciences recently laid off nearly 200 employees after reporting disappointing first-quarter sales.

Element still has a long way to go in its bid to rival Illumina, a genomics giant that dominates 80% of the sequencing market and has more than 23,000 instruments in use around the world. That includes the NextSeq 2000, a $335,000 sequencer with a similar output to Aviti. Element is betting its blend of accuracy and a more moderate price point can help it carve out a niche of academic and biopharma customers.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： What does generative AI mean for health care? We asked experts
Next article： Pope Francis asks Church to identify 21st

WSS

National associations that represent hospice owe an apology

Roche's accidental data boosts hopes for anti

Wegovy improves function in certain heart failure patients

Hospital at home shows how to bring innovation to health care

Roche's accidental data boosts hopes for anti

Wegovy improves function in certain heart failure patients

entertainment

hotspot

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

hotspot

United colonoscopy coverage change 'may cost lives,' doctors say

FDA greenlights medical device to combat bladder issues

Sports medicine is finally prioritizing gender equality

FDA greenlights medical device to combat bladder issues

Drug repurposing or repositioning? The language matters

Biden's Plan B on student loan forgiveness relies on Higher Education Act: What to know

23andMe had bad news about my health. I wish a person had delivered it

Suspect in Ukraine detonates explosives at a courthouse, killing himself and wounding 2 officers

Trump demands the U.S. pay no more for drugs than other countries … again

DeSantis wants to import drugs. Biden’s FDA blasted his plan

hotspot

Wegovy improves function in certain heart failure patients

Man with guns arrested near Obama home 'attempted to evade' Secret Service: Prosecutors

How the first Native Hawaiian psychiatrist helped diversify medicine

California store owner shot dead in dispute over displaying Pride flag: Police

Wegovy improves function in certain heart failure patients

How the drug

focus

knowledge

hotspot

focus